Stay updated on Amivantamab Combo Therapy Clinical Trial

Sign up to get notified when there's something new on the Amivantamab Combo Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab Combo Therapy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    July 2026 update dates were added to the study record’s update history, and June 2026 dates were removed. This indicates a recent refresh of the page.
    Difference
    0.1%
    Check dated 2026-07-11T05:29:18.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.2 to v3.6.3, indicating a small update to the page metadata.
    Difference
    0.0%
    Check dated 2026-07-03T23:43:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates that the study documents have been updated to a newer version.
    Difference
    0.0%
    Check dated 2026-06-27T00:08:33.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Recruitment status now indicates no participants are being sought, and the page adds guidance sections for readers (How to Read a Study Record, Common Questions, How to Join a Study) along with minor label formatting changes to Intervention/Treatment.
    Difference
    0.3%
    Check dated 2026-06-12T16:37:41.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision tag on the page updated to v3.5.5, replacing the previous v3.5.4. This indicates a new build/revision label without altering the available content or functionality.
    Difference
    0.0%
    Check dated 2026-06-05T11:47:17.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A new publication citation by Tang et al. was added to the Publications section, describing amivantamab plus chemotherapy versus chemotherapy for EGFR Exon 20 insertion NSCLC in a Chinese mainland subgroup analysis of the PAPILLON trial.
    Difference
    0.0%
    Check dated 2026-05-29T07:37:29.000Z thumbnail image

Stay in the know with updates to Amivantamab Combo Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo Therapy Clinical Trial page.